Deferred publication: Advanced NSCLC
LBA2_PR: Osimertinib (AZD9291) in pre-treated pts with T790M-positive advanced NSCLC: updated Phase 1 (P1) and pooled Phase 2 (P2) results

https://doi.org/10.1016/S1556-0864(16)30325-2Get rights and content
Under an Elsevier user license
open archive

Cited by (0)